Lung cancer

In this Sunday, Oct. 22, 2017 file photo, New York Jets quarterback Josh McCown (15) looks to pass during the first half of an NFL football game against the Miami Dolphins in Miami Gardens, Fla. The Carolina Panthers are roaring into their favorite part of the season. It's the home stretch with six games, and at 7-3 with a three-game winning streak, it's no surprise the Panthers are starting to heat up. The Carolina Panthers play the Jets on Sunday, Nov. 26, 2017. Both the Panthers and Jets are coming off bye-week breaks, so they're well-rested. (AP Photo/Wilfredo Lee, File)
November 24, 2017 - 6:41 pm
Josh McCown and Julius Peppers will greet each other on the field at some point Sunday before their teams square off, knowing they're part of an exclusive — and dwindling — NFL club. The New York Jets quarterback and Carolina Panthers defensive end are two of only three active players who were...
Read More
September 13, 2017 - 3:10 pm
NEW YORK (AP) — Veteran broadcaster Larry King says he battled lung cancer this summer but appears to have the disease at bay. The former CNN host, who is 83, told Us Weekly that a spot on his lung was noticed this summer during a routine check-up. He said he had surgery in July. The tumor was...
Read More
FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab's maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File)
August 27, 2017 - 5:03 am
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an...
Read More
This undated combination of photos provided by the Journal of the American Medical Association in July 2017 shows a cancer patient with gray hair that unexpectedly turned dark while taking new immunotherapy drugs. Fourteen such cases were among 52 lung cancer patients being followed to see whether they developed bad side effects from the drugs - Keytruda, Opdivo and Tecentriq. (JAMA via AP)
July 21, 2017 - 11:40 am
CHICAGO (AP) — Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads. Chemotherapy is notorious for making hair fall out, but the 14 patients involved were all being treated with new immunotherapy drugs that work...
Read More
Chemotherapy drugs are administered to a patient at North Carolina Cancer Hospital in Chapel Hill, N.C., on Thursday, May 25, 2017. According to new studies released at a June 2017 American Society of Clinical Oncology conference, drugs are scoring big gains against some of the most common cancers, setting new standards of care for many prostate, breast and lung tumors. (AP Photo/Gerry Broome)
June 05, 2017 - 7:33 am
CHICAGO (AP) — Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease. What's striking: The drugs are beneficial in some cases for more than a year, much...
Read More
FILE - In this Friday, Aug. 12, 2005 file photo, Dr. Claudia Henschke, chief of the Division of Chest Imaging, right, and CT supervisor Gus Daphnis watch the lung scan of a patient at New York Hospital - Cornell Medical Center in New York. The test, called a spiral or helical CT scan, detects lung abnormalities as small as 5 millimeters, less than a fifth of an inch. In results published Wednesday, April 26, 2017 by Nature and the New England Journal of Medicine, researchers have taken an important step toward better lung cancer treatment. Using experimental tests that detect bits of DNA that tumors shed into the blood, they were able to track genetic changes in early-stage cases over time, and to find some recurrences up to a year before imaging scans could, giving a chance to try new therapy sooner. (AP Photo/Richard Drew)
April 26, 2017 - 2:59 pm
BOSTON (AP) — Researchers have taken an important step toward better lung cancer treatment by using blood tests to track genetic changes in tumors as they progress from their very earliest stages. With experimental tests that detect bits of DNA that tumors shed into the blood, they were able to...
Read More
FILE - In this Friday, Aug. 12, 2005 file photo, Dr. Claudia Henschke, chief of the Division of Chest Imaging, right, and CT supervisor Gus Daphnis watch the lung scan of a patient at New York Hospital - Cornell Medical Center in New York. The test, called a spiral or helical CT scan, detects lung abnormalities as small as 5 millimeters, less than a fifth of an inch. In results published Wednesday, April 26, 2017 by Nature and the New England Journal of Medicine, researchers have taken an important step toward better lung cancer treatment. Using experimental tests that detect bits of DNA that tumors shed into the blood, they were able to track genetic changes in early-stage cases over time, and to find some recurrences up to a year before imaging scans could, giving a chance to try new therapy sooner. (AP Photo/Richard Drew)
April 26, 2017 - 1:10 pm
BOSTON (AP) — Researchers have taken an important step toward better lung cancer treatment by using blood tests to track genetic changes in tumors as they progress from their very earliest stages. With experimental tests that detect bits of DNA that tumors shed into the blood, they were able to...
Read More

Pages